2014 Sep 1. pii: jrheum.140683. [Epub ahead of print]
Cannabis in the Treatment of Rheumatic Diseases: Suggestions for a Reasoned Approach.
Abstract
On April 1, 2014, Health Canada announced a new approach to the permitted use of herbal cannabis as a medication (“medical marijuana”). Physicians are now required to write prescriptions, which the patients must have filled by producers licensed by Health Canada who will sell standard preparations of known purity. Numerous medical organizations, such as the Canadian Medical Association, the College of Family Physicians of Canada, and the Canadian Ophthalmological Society, have expressed their disapproval either of the use of cannabis as a medication, or of the requirement for physicians to write prescriptions for a substance that has not yet been formally approved as a safe and efficacious medication by Health Canada itself.
- PMID:
- 25179852
- [PubMed – as supplied by publisher]
